sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
STD Diagnostics Market by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing and Others) and by Testing Devices (Laboratory Devices and Point of Care Devices) for Hospitals and Other End Users - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

STD Diagnostics Market by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea...

Home / Categories / Healthcare
STD Diagnostics Market by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing and Others) and by Testing Devices (Laboratory Devices and Point of Care Devices) for Hospitals and Other End Users - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021
STD Diagnostics Market by Type...
Report Code
RO1/106/1009

Publish Date
16/Dec/2016

Pages
110
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

The report covers forecast and analysis for the STD diagnostics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the STD diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the STD diagnostics market on a global level.


This report offers comprehensive cov

The report covers forecast and analysis for the STD diagnostics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the STD diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the STD diagnostics market on a global level.


This report offers comprehensive coverage on global STD diagnostics market along with, market trends, drivers, and restraints of STD diagnostics market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the STD diagnostics market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.


The study provides a decisive view on the STD diagnostics market by segmenting the market based on type, end- users, testing device, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The type market covered under this study includes chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papilloma virus testing, human immunodeficiency virus testing and others. The end-users segmentation includes hospitals and others. The testing device segmentation includes laboratory device and point of care device. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further segmented into the U.S., UK, Germany, France, Japan, China, India, and Brazil.  


The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global STD diagnostics market include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure.


This report segments the global STD diagnostics market as follows:


Global STD Diagnostics Market: Type Analysis



  • Chlamydia testing

  • Syphilis testing

  • Gonorrhea testing

  • Herpes Simplex Virus testing

  • Human Papilloma Virus testing

  • Human Immunodeficiency Virus testing

  • Others


Global STD Diagnostics Market: End- Users Analysis



  • Hospitals

  • Others


Global STD Diagnostics Market: Testing Device Analysis



  • Laboratory Devices

  • Point of Care Devices


Global STD Diagnostics Market: Regional Segment Analysis



  • North America

    • U.S.



  • Europe

    • UK

    • Germany

    • France



  • Asia Pacific

    • China

    • Japan

    • India



  • Latin America

    • Brazil



  • Middle East And Africa

rage on global STD diagnostics market along with, market trends, drivers, and restraints of STD diagnostics market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the STD diagnostics market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.


The study provides a decisive view on the STD diagnostics market by segmenting the market based on type, end- users, testing device, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The type market covered under this study includes chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papilloma virus testing, human immunodeficiency virus testing and others. The end-users segmentation includes hospitals and others. The testing device segmentation includes laboratory device and point of care device. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further segmented into the U.S., UK, Germany, France, Japan, China, India, and Brazil.  


The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global STD diagnostics market include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure.


This report segments the global STD diagnostics market as follows:


Global STD Diagnostics Market: Type Analysis



  • Chlamydia testing

  • Syphilis testing

  • Gonorrhea testing

  • Herpes Simplex Virus testing

  • Human Papilloma Virus testing

  • Human Immunodeficiency Virus testing

  • Others


Global STD Diagnostics Market: End- Users Analysis



  • Hospitals

  • Others


Global STD Diagnostics Market: Testing Device Analysis



  • Laboratory Devices

  • Point of Care Devices


Global STD Diagnostics Market: Regional Segment Analysis



  • North America

    • U.S.



  • Europe

    • UK

    • Germany

    • France



  • Asia Pacific

    • China

    • Japan

    • India



  • Latin America

    • Brazil



  • Middle East And Africa

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com